October 04, 2013
A New York federal judge on Thursday delayed the transfer of hundreds of lawsuits in multidistrict litigation over jaw injuries allegedly caused by the bone drug Fosamax in order to give the plaintiffs and Merck & Co. Inc. time to potentially reach a settlement.